AI & ChatGPT searches , social queriess for FULRANUMAB

Search references for FULRANUMAB. Phrases containing FULRANUMAB

See searches and references containing FULRANUMAB!

AI searches containing FULRANUMAB

FULRANUMAB

  • Fulranumab

    • Chemical compound

    Fulranumab is a monoclonal antibody against nerve growth factor. It was designed for the treatment of pain. Johnson & Johnson licensed the drug from Amgen

    Fulranumab

    Fulranumab

  • Monoclonal antibody

    • Antibodies from clones of the same blood cell

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Monoclonal antibody

    Monoclonal antibody

    Monoclonal_antibody

  • List of investigational analgesics

    • (REGN-475, SAR-164877) – monoclonal antibody against nerve growth factor Fulranumab (AMG-403, JNJ-42160443) – monoclonal antibody against nerve growth factor

    List of investigational analgesics

    List_of_investigational_analgesics

  • Abelacimab

    • Monoclonal antibody

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Abelacimab

    Abelacimab

  • Donanemab

    • Monoclonal antibody against amyloid beta

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Donanemab

    Donanemab

  • Postherpetic neuralgia

    • Pain due to peripheral nerve damage following infection by the shingles virus

    oxycodone e hydromorphone) and nerve growth factor (NGF) inhibition (fulranumab). Of them, some of them report promising results while others did not

    Postherpetic neuralgia

    Postherpetic_neuralgia

  • ACD856

    • TrkA and TrkB positive modulator

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    ACD856

    ACD856

  • Trevogrumab

    • Monoclonal antibody

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Trevogrumab

    Trevogrumab

  • Lecanemab

    • Monoclonal antibody against amyloid beta

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Lecanemab

    Lecanemab

  • Evolocumab

    • Pharmaceutical drug

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Evolocumab

    Evolocumab

  • Testosterone

    • Primary male sex hormone

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Testosterone

    Testosterone

    Testosterone

  • Bevacizumab

    • Medication

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Bevacizumab

    Bevacizumab

  • Bimagrumab

    • Chemical compound

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Bimagrumab

    Bimagrumab

  • Insulin

    • Peptide hormone

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Insulin

    Insulin

    Insulin

  • Amitriptyline

    • Tricyclic antidepressant

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Amitriptyline

    Amitriptyline

    Amitriptyline

  • Emicizumab

    • Monoclonal antibody

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Emicizumab

    Emicizumab

    Emicizumab

  • Dexamethasone

    • Corticosteroid medication

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Dexamethasone

    Dexamethasone

    Dexamethasone

  • Humanized antibody

    • Antibodies from non-human species made nearly identical with human ones

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Humanized antibody

    Humanized_antibody

  • Romosozumab

    • Pharmaceutical drug

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Romosozumab

    Romosozumab

  • Fremanezumab

    • Pharmaceutical biological monoclonal antibody

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Fremanezumab

    Fremanezumab

  • Vascular endothelial growth factor

    • Protein involved in blood vessel growth

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Vascular endothelial growth factor

    Vascular_endothelial_growth_factor

  • Dabrafenib

    • Anti-cancer medication

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Dabrafenib

    Dabrafenib

    Dabrafenib

  • Cerebrolysin

    • Experimental drug for neurodegenerative disorders

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Cerebrolysin

    Cerebrolysin

  • Faricimab

    • Medication for macular degeneration

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Faricimab

    Faricimab

    Faricimab

  • IGF-1 LR3

    • Synthetic protein

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    IGF-1 LR3

    IGF-1_LR3

  • Wnt signaling pathway

    • Group of signal transduction pathways involved in embryonic development

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Wnt signaling pathway

    Wnt_signaling_pathway

  • Dihexa

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Dihexa

    Dihexa

    Dihexa

  • Insulin-like growth factor 1

    • Protein found in humans

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Insulin-like growth factor 1

    Insulin-like growth factor 1

    Insulin-like_growth_factor_1

  • Imatinib

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Imatinib

    Imatinib

    Imatinib

  • Adult neurogenesis

    • Generating of neurons from neural stem cells in adults

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Adult neurogenesis

    Adult neurogenesis

    Adult_neurogenesis

  • Integrin

    • Transmembrane receptors involved in cellular adhesion and signalling

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Integrin

    Integrin

    Integrin

  • Aducanumab

    • Monoclonal antibody against amyloid beta

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Aducanumab

    Aducanumab

  • Concizumab

    • Medication

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Concizumab

    Concizumab

  • Marstacimab

    • Medication

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Marstacimab

    Marstacimab

  • Platelet-derived growth factor

    • Signaling glycoprotein regulating cell proliferation

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Platelet-derived growth factor

    Platelet-derived growth factor

    Platelet-derived_growth_factor

  • Galcanezumab

    • Monoclonal antibody

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Galcanezumab

    Galcanezumab

    Galcanezumab

  • Prasinezumab

    • Experimental monoclonal antibody

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Prasinezumab

    Prasinezumab

  • Hemopoietic growth factor

    • Class of proteins

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Hemopoietic growth factor

    Hemopoietic_growth_factor

  • Growth factor

    • Protein or other substance that stimulates cellular proliferation

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Growth factor

    Growth_factor

  • HER2

    • Mammalian protein found in humans

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    HER2

    HER2

    HER2

  • Trastuzumab

    • Medication

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Trastuzumab

    Trastuzumab

    Trastuzumab

  • Erythropoietin

    • Protein that stimulates red blood cell production

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Erythropoietin

    Erythropoietin

    Erythropoietin

  • Denosumab

    • Human monoclonal antibody

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Denosumab

    Denosumab

  • Tyrosine kinase inhibitor

    • Drug typically used in cancer treatment

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Tyrosine kinase inhibitor

    Tyrosine kinase inhibitor

    Tyrosine_kinase_inhibitor

  • Cetuximab

    • Pharmaceutical drug

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Cetuximab

    Cetuximab

    Cetuximab

  • ERBB3

    • Protein found in humans

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    ERBB3

    ERBB3

    ERBB3

  • Receptor tyrosine kinase

    • Class of enzymes

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Receptor tyrosine kinase

    Receptor tyrosine kinase

    Receptor_tyrosine_kinase

  • Anti-amyloid antibodies

    • Drug class

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Anti-amyloid antibodies

    Anti-amyloid_antibodies

  • Epidermal growth factor

    • Protein that stimulates cell division and differentiation

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Epidermal growth factor

    Epidermal growth factor

    Epidermal_growth_factor

  • Trastuzumab deruxtecan

    • Medication

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Trastuzumab deruxtecan

    Trastuzumab deruxtecan

    Trastuzumab_deruxtecan

  • Caplacizumab

    • Chemical compound

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Caplacizumab

    Caplacizumab

  • Anti-VEGF

    • Medication which blocks growth of blood vessels

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Anti-VEGF

    Anti-VEGF

    Anti-VEGF

  • Alirocumab

    • Pharmaceutical drug

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Alirocumab

    Alirocumab

  • Filgrastim

    • Medication

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Filgrastim

    Filgrastim

    Filgrastim

  • List of therapeutic monoclonal antibodies

    • nerve growth factor (NGF) Y pain associated with osteoarthritis in cats Fulranumab mab human nerve growth factor (NGF) pain Futuximab mab chimeric Epidermal

    List of therapeutic monoclonal antibodies

    List of therapeutic monoclonal antibodies

    List_of_therapeutic_monoclonal_antibodies

  • Fibroblast growth factor

    • Family of proteins involved in anatomical development

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Fibroblast growth factor

    Fibroblast_growth_factor

  • Ramucirumab

    • Pharmaceutical drug

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Ramucirumab

    Ramucirumab

  • Osimertinib

    • Chemical compound, used as a medication to treat lung cancer

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Osimertinib

    Osimertinib

    Osimertinib

  • Brain-derived neurotrophic factor

    • Protein found in humans

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Brain-derived neurotrophic factor

    Brain-derived neurotrophic factor

    Brain-derived_neurotrophic_factor

  • Bedinvetmab

    • Monoclonal antibody

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Bedinvetmab

    Bedinvetmab

    Bedinvetmab

  • Trastuzumab emtansine

    • Pharmaceutical drug

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Trastuzumab emtansine

    Trastuzumab emtansine

    Trastuzumab_emtansine

  • Repotrectinib

    • Medication

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Repotrectinib

    Repotrectinib

    Repotrectinib

  • Dehydroepiandrosterone

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Dehydroepiandrosterone

    Dehydroepiandrosterone

    Dehydroepiandrosterone

  • Brolucizumab

    • Pharmaceutical drug

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Brolucizumab

    Brolucizumab

  • Lenvatinib

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Lenvatinib

    Lenvatinib

    Lenvatinib

  • Fruquintinib

    • Medication

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Fruquintinib

    Fruquintinib

    Fruquintinib

  • Hepatocyte growth factor

    • Mammalian protein found in Homo sapiens

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Hepatocyte growth factor

    Hepatocyte_growth_factor

  • Tropoflavin

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Tropoflavin

    Tropoflavin

    Tropoflavin

  • Idarucizumab

    • Medication

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Idarucizumab

    Idarucizumab

  • Eptinezumab

    • Monoclonal antibody

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Eptinezumab

    Eptinezumab

  • Vemurafenib

    • Targeted cancer drug

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Vemurafenib

    Vemurafenib

    Vemurafenib

  • Dasatinib

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Dasatinib

    Dasatinib

    Dasatinib

  • Antineoplastic

    • Class of drugs used to treat malignant tumors

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Antineoplastic

    Antineoplastic

    Antineoplastic

  • Erenumab

    • Chemical compound

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Erenumab

    Erenumab

    Erenumab

  • Insulin-like growth factor

    • Proteins similar to insulin that stimulate cell proliferation

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Insulin-like growth factor

    Insulin-like growth factor

    Insulin-like_growth_factor

  • Pazopanib

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Pazopanib

    Pazopanib

  • Gantenerumab

    • Monoclonal antibody protein

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Gantenerumab

    Gantenerumab

    Gantenerumab

  • Nerve growth factor

    • Mammalian protein found in humans

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Nerve growth factor

    Nerve growth factor

    Nerve_growth_factor

  • Neurotrophic factors

    • Family of biomolecules

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Neurotrophic factors

    Neurotrophic_factors

  • Anti-α-synuclein drug

    • Drugs that inhibit α-synuclein

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Anti-α-synuclein drug

    Anti-α-synuclein_drug

  • Epidermal growth factor receptor

    • Transmembrane protein

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Epidermal growth factor receptor

    Epidermal growth factor receptor

    Epidermal_growth_factor_receptor

  • Crenolanib

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Crenolanib

    Crenolanib

    Crenolanib

  • FGF19

    • Protein-coding gene in the species Homo sapiens

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    FGF19

    FGF19

    FGF19

  • Insulin-like growth factor 1 receptor

    • Cell receptor protein found in humans

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Insulin-like growth factor 1 receptor

    Insulin-like growth factor 1 receptor

    Insulin-like_growth_factor_1_receptor

  • Evinacumab

    • Monoclonal antibody

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Evinacumab

    Evinacumab

  • Bapineuzumab

    • Chemical compound

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Bapineuzumab

    Bapineuzumab

  • Tyrosine kinase

    • Enzyme

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Tyrosine kinase

    Tyrosine kinase

    Tyrosine_kinase

  • Burosumab

    • Monoclonal antibody designed to treat X-linked hypophosphatemia

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Burosumab

    Burosumab

  • Amivantamab

    • Monoclonal antibody

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Amivantamab

    Amivantamab

    Amivantamab

  • Encorafenib

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Encorafenib

    Encorafenib

    Encorafenib

  • Solanezumab

    • Monoclonal antibody medication

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Solanezumab

    Solanezumab

  • Nintedanib

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Nintedanib

    Nintedanib

    Nintedanib

  • Abciximab

    • Pharmaceutical compound

    drugs Aducanumab‡ Donanemab Gantenerumab† Lecanemab Erenumab Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab

    Abciximab

    Abciximab

    Abciximab

  • Nilotinib

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Nilotinib

    Nilotinib

    Nilotinib

  • Eutropoflavin

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Eutropoflavin

    Eutropoflavin

    Eutropoflavin

  • Fibroblast growth factor 23

    • Protein found in humans

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Fibroblast growth factor 23

    Fibroblast growth factor 23

    Fibroblast_growth_factor_23

  • Dehydroepiandrosterone sulfate

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Dehydroepiandrosterone sulfate

    Dehydroepiandrosterone sulfate

    Dehydroepiandrosterone_sulfate

  • Fibroblast growth factor 21

    • Protein-coding gene in mammals

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Fibroblast growth factor 21

    Fibroblast growth factor 21

    Fibroblast_growth_factor_21

  • KIT (gene)

    • Mammalian protein and protein-coding gene

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    KIT (gene)

    KIT (gene)

    KIT_(gene)

  • Ponazuril

    • Chemical compound

    Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors:

    Ponazuril

    Ponazuril

    Ponazuril

AI & ChatGPT searchs for online references containing FULRANUMAB

FULRANUMAB

AI search references containing FULRANUMAB

FULRANUMAB

AI search queriess for Facebook and twitter posts, hashtags with FULRANUMAB

FULRANUMAB

Follow users with usernames @FULRANUMAB or posting hashtags containing #FULRANUMAB

FULRANUMAB

Online names & meanings

  • TotaSingh

    • Boy/Male

    Indian, Punjabi, Sikh

    TotaSingh

    Parrot

  • Tilda

    • Girl/Female

    Swedish American Teutonic French German

    Tilda

    Heroine.

  • Elmeena

    • Girl/Female

    German

    Elmeena

    Will; Helmet

  • Aadilakshmi

    • Girl/Female

    Indian, Kannada, Marathi

    Aadilakshmi

    Goddess Laxmi

  • Corina

    • Girl/Female

    American, Australian, British, Christian, Dutch, English, Finnish, French, German, Greek, Latin, Portuguese, Swedish

    Corina

    Maiden

  • Shamshad | شمشاد

    • Boy/Male

    Muslim

    Shamshad | شمشاد

    Beautiful

  • Chandanwant

    • Boy/Male

    Indian, Punjabi, Sikh

    Chandanwant

    Full of Sandal's Fragrance

  • Lohitha | லோஹீத 

    • Girl/Female

    Tamil

    Lohitha | லோஹீத 

    Red, Ruby, Goddess Lakshmi in the form of iron

  • Dharmadasa

    • Boy/Male

    Hindu, Indian

    Dharmadasa

    Servant of Dharma or Religion Duty that which is Good

  • Dheivamani

    • Boy/Male

    Gujarati, Hindu, Indian, Kannada, Marathi, Tamil, Telugu

    Dheivamani

    Blessed Gem

AI search & ChatGPT queriess for Facebook and twitter users, user names, hashtags with FULRANUMAB

FULRANUMAB

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing FULRANUMAB

FULRANUMAB

AI searchs for Acronyms & meanings containing FULRANUMAB

FULRANUMAB

AI searches, Indeed job searches and job offers containing FULRANUMAB

Other words and meanings similar to

FULRANUMAB

AI search in online dictionary sources & meanings containing FULRANUMAB

FULRANUMAB